Replies to post #691907 on NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

I have no doubt it happened. You can see around the same time LP signed two collaboration deal with two main players on checking point inhibitors. Colorectal trial with Merck and rGBM, a much tougher target with BMS. Merck cannot terminate the colorectal trial and then later became one of the collaborators of the combo trial with the termination of the collaboration trial between BMS and NWBO.

I suspect the reason they chose trial site at EU is that before January 2023, clinical trial was not required to be registered on public website.

[XMaster2023]

“Obviously, he has no control over FDA decisions” I don’t know if I would agree with this statement. Granted he doesn’t sign for approval, however the president definitely has influence over the director of the FDA and the CDC as seen during the Trump administration. We all observed the good, the bad, and the ugly side of that influence.

[Troymister]

Great idea.